Lovegra
Lovegra

2.25
A clinical formulation indicated for Women's Health. This product supports blood flow to specific peripheral regions to optimize physiological response and physical comfort.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Sildenafil Citrate
Reference Brand
Female Viagra
Product Origin
Generic Brand
Product Manufacturer
Ajanta Pharma
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Women's Health, Sexual Wellness
Product Category
PDE5 Inhibitor
Pharmacological Class
Phosphodiesterase type 5 (PDE5) inhibitor
Clinical Indications
Manufacturer Description
A PDE5 inhibitor utilized to manage female sexual arousal concerns by designed to support blood flow to target improved arousal and sexual satisfaction.
Mechanism of Action
It works by increasing blood flow to the genital area. By inhibiting the PDE5 enzyme, it promotes the relaxation of smooth muscle and enhances sensitivity during stimulation.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
4–6 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Uncontrolled hypertension, Allergy to sildenafil
Severe Adverse Events
Sudden vision loss, Sudden hearing loss, Severe hypotension, Serious allergic reaction
Common Side Effects
Headache, Flushing, Nasal congestion, Upset stomach
Uncommon Side Effects
Dizziness, Muscle pain, Blurred vision
Drug Interactions
Nitrates, Alpha-blockers, Erythromycin, Ketoconazole, Ritonavir
Pregnancy Safety Warnings
Not intended for use during pregnancy.
Age Restrictions
For adult women.
Storage Guidelines
Store at room temperature in a dry place.
Related Products
Addyi, Vyleesi
Information for Lovegra is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories